SANUWAVE Health, Inc. (SNWV) · Oct 28, 2026 · Material agreement
Covenant waiver — Fixed-charge coverage ratio below required level; secured debt and investment baskets cut from $500,000 to $250,000
SANUWAVE’s credit amendment waives a fixed-charge covenant breach, but adds lender consent rights and cuts permitted debt and investment capacity.
SANUWAVE is commercializing its UltraMIST wound-care system and recurring applicators, but its 2026 operating backdrop has weakened: reimbursement pressures and a growing used-system market have hurt new system sales, while applicator demand remains comparatively resilient.
The amendment confirms real covenant pressure, not routine paperwork. Lenders waived a default tied to the company’s fixed-charge coverage ratio for the twelve months ended September 30, 2026, meaning operating cash generation was not sufficient to meet the existing test. 〔0〕
The waiver buys time but comes with tighter lender supervision. SANUWAVE now needs written lender consent for most permitted acquisitions and restricted equity repurchases, while the baskets for other secured debt and subsidiary investments were cut from $500,000 to $250,000. This limits financial flexibility precisely as the company works through softer capital-equipment demand and an already leveraged balance sheet; its existing facility includes a $23 million term loan and a $5 million revolver.
The immediate liquidity relief is more important than the $5,000 fee. The lenders did not declare an acceleration or force a refinancing, so the amendment prevents a near-term technical default. But it does not provide new capital or improve the underlying coverage problem; it formalizes a more restrictive relationship with creditors.
Bottom line: This is a defensive financing amendment: SANUWAVE avoids an immediate covenant default, but the need for a waiver and tighter restrictions signals that its operating recovery is under pressure and its room to maneuver has narrowed.
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!